Compare MASI & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MASI | BAX |
|---|---|---|
| Founded | 1989 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 10.2B |
| IPO Year | 2000 | 1994 |
| Metric | MASI | BAX |
|---|---|---|
| Price | $178.19 | $16.67 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 9 |
| Target Price | ★ $184.25 | $22.13 |
| AVG Volume (30 Days) | 2.0M | ★ 8.1M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | ★ 51.05 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,239,153,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $8.59 | $1.90 |
| Revenue Next Year | $7.60 | $2.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.34 | 5.72 |
| 52 Week Low | $125.94 | $16.84 |
| 52 Week High | $176.42 | $34.52 |
| Indicator | MASI | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 79.04 | 33.21 |
| Support Level | $157.54 | N/A |
| Resistance Level | N/A | $19.31 |
| Average True Range (ATR) | 0.37 | 0.74 |
| MACD | -1.12 | -0.19 |
| Stochastic Oscillator | 98.79 | 2.77 |
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.